(Q40993134)

25 September 2017

1 reference

title

HIV viral load markers in clinical practice (English)

1 reference

25 September 2017

1 reference

1 reference

2

1 reference

25 September 2017

1

Saag MS

1 reference

25 September 2017

5

Coombs R

1 reference

25 September 2017

3

Kuritzkes DR

1 reference

25 September 2017

O'Brien WA

4

1 reference

25 September 2017

Poscher ME

6

1 reference

25 September 2017

Jacobsen DM

7

1 reference

25 September 2017

Shaw GM

8

1 reference

25 September 2017

Richman DD

9

1 reference

25 September 2017

Volberding PA

10

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

25 September 2017

1 reference

25 September 2017

volume

2

1 reference

25 September 2017

issue

6

1 reference

25 September 2017

page(s)

625-629

1 reference

http://data.medicalrecords.com/medicalrecords/healthwise/hiv_viral_load

25 September 2017

WordLift URL

1 reference

https://www.medicalrecords.com/health-a-to-z/hiv-viral-load-definition/

cites work

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

Plasma viremia in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

NASBATM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

A Pilot Study to Evaluate the Development of Resistance to Nevirapine in Asymptomatic Human Immunodeficiency Virus-Infected Patients with CD4 Cell Counts of >500/mm3 : AIDS Clinical Trials Group Protocol 208

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

7 January 2021

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

7 January 2021

Clinical Evaluation of Branched DNA Signal Amplification for Quantifying HIV Type 1 in Human Plasma

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

7 January 2021

Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team.

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

7 January 2021

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

7 January 2021

Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

7 January 2021

Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

7 January 2021

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

7 January 2021

Activation of virus replication after vaccination of HIV-1-infected individuals.

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-625

7 January 2021

Identifiers

DOI

10.1038/NM0696-625

1 reference

25 September 2017

1 reference